240 related articles for article (PubMed ID: 31790854)
1. Ventricular late potentials and myocardial fibrosis in hypertrophic cardiomyopathy.
Matsuki A; Kawasaki T; Kawamata H; Sakai C; Harimoto K; Kamitani T; Yamano M; Matoba S
J Electrocardiol; 2020; 58():87-91. PubMed ID: 31790854
[TBL] [Abstract][Full Text] [Related]
2. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
[TBL] [Abstract][Full Text] [Related]
3. Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging.
Song BG; Yang HS; Hwang HK; Kang GH; Park YH; Chun WJ; Oh JH
Clin Cardiol; 2013 Jan; 36(1):31-5. PubMed ID: 23070984
[TBL] [Abstract][Full Text] [Related]
4. QRS-T angle in patients with Hypertrophic Cardiomyopathy - A comparison with Cardiac Magnetic Resonance Imaging.
Jensen CJ; Lambers M; Zadeh B; Wambach JM; Nassenstein K; Bruder O
Int J Med Sci; 2021; 18(3):821-825. PubMed ID: 33437218
[No Abstract] [Full Text] [Related]
5. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
[TBL] [Abstract][Full Text] [Related]
6. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
7. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
[TBL] [Abstract][Full Text] [Related]
8. Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study.
Habib M; Adler A; Fardfini K; Hoss S; Hanneman K; Rowin EJ; Maron MS; Maron BJ; Rakowski H; Chan RH
JACC Cardiovasc Imaging; 2021 May; 14(5):947-958. PubMed ID: 33248971
[TBL] [Abstract][Full Text] [Related]
9. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
Langer C; Schaefer P; Lutz M; Eden M; Hohnhorst M; Harders H; Faber L; Jansen O; Both M; Frey N
J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
[TBL] [Abstract][Full Text] [Related]
10. High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.
Österberg AW; Östman-Smith I; Jablonowski R; Carlsson M; Green H; Gunnarsson C; Liuba P; Fernlund E
Pediatr Cardiol; 2021 Mar; 42(3):492-500. PubMed ID: 33515326
[TBL] [Abstract][Full Text] [Related]
11. Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.
Wang C; Zheng J; Sun J; Wang Y; Xia R; Yin Q; Chen W; Xu Z; Liao J; Zhang B; Gao F
J Cardiol; 2015 Dec; 66(6):520-6. PubMed ID: 25981868
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Prognosis of Presence and Location of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Imaging in Patients with Hypertrophic Cardiomyopathy: a Single-Center Cohort Study.
Li X; Lai L; Luo R; Yang H; Ma H; Yang Z; Zhao S; Su W; Hua W
J Cardiovasc Transl Res; 2021 Oct; 14(5):1001-1016. PubMed ID: 33629154
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
[TBL] [Abstract][Full Text] [Related]
14. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
[TBL] [Abstract][Full Text] [Related]
15. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
16. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia.
Sakamoto N; Sato N; Oikawa K; Karim Talib A; Sugiyama E; Minoshima A; Tanabe Y; Takeuchi T; Akasaka K; Saijo Y; Kawamura Y; Hasebe N
Heart Rhythm; 2015 Aug; 12(8):1747-55. PubMed ID: 25916568
[TBL] [Abstract][Full Text] [Related]
17. The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients.
Riza Demir A; Celik Ö; Sevinç S; Uygur B; Kahraman S; Yilmaz E; Cemek M; Onal Y; Erturk M
Ann Noninvasive Electrocardiol; 2019 Sep; 24(5):e12672. PubMed ID: 31152489
[TBL] [Abstract][Full Text] [Related]
18. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
[TBL] [Abstract][Full Text] [Related]
19. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
[TBL] [Abstract][Full Text] [Related]
20. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
